Pfizer Profit Matches Analyst Estimates as It Narrows Forecast

Pfizer Profit Matches Analyst Estimates as It Narrows Forecast

JB Reed/Bloomberg

Pfizer Inc.'s cholesterol drug Lipitor is arranged for a photograph at New London Pharmacy in New York. Pfizer Inc., the world’s biggest drugmaker, narrowed its 2012 forecast after reporting third-quarter earnings that met analyst estimates.